Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 5NIH 2NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 16Lymphoid 8Breast 6Sarcoma 4Genitourinary 4CNS 3Plasma cell 2Other neoplasm 1Head & Neck 1Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Endometrial Serous Adenocarcinoma 1

Interventions

Cisplatin 63Paclitaxel 56Carboplatin 38Taxes 24Radiotherapy 21Gemcitabine 16Brachytherapy 15Filgrastim 14Doxorubicin 13Topotecan 12Platinum 121,2-diaminocyclohexaneplatinum II citrate 12Docetaxel 11Radiation 7Granulocyte Colony-Stimulating Factor 7Chemotherapy, Adjuvant 7pegfilgrastim 6Surgical Procedures, Operative 6Radiotherapy, Intensity-Modulated 6Polymerase Chain Reaction 6Ifosfamide 6Etoposide 6Watchful Waiting 5Radiotherapy, Conformal 5Pemetrexed 5Gene Expression Profiling 5Fluorouracil 5Celecoxib 5Amifostine 5Observation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Microarray Analysis × Gynecologic × Clear all
NCT01344837 2024-08-14

Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer

GOG Foundation

Completed
360 enrolled
Gynecologic

Endometrial Serous Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡